Rick Silva

Executive Director, Biomedical Corporate Alliances
University of Arizona Health Sciences

(520) 621-4789

Rick Silva, PhD, is executive director, biomedical corporate alliances, at the University of Arizona Health Sciences (UAHS). Dr. Silva, a leader in academic biomedical research commercialization, is responsible for developing and managing UA-industry partnerships in biomedical research.

Dr. Silva works closely with Tech Launch Arizona, the UA unit dedicated to commercializing the inventions emanating from university research, as well as with the UA Foundation, the UA Alumni Association, public and private entities and other stakeholders, to develop UAHS industry-sponsored clinical trials and expand shared research facilities and services, including biospecimen repositories, clinical data and biomaterials. He works to integrate faculty and facilities across the UA campus, providing expertise in industry-university partnerships and alliance management in UAHS-focused biomedical research.

Prior to his appointment at UAHS, Dr. Silva was with the University of Colorado Denver Technology Transfer Office for 14 years, serving as senior director since 2012. He worked with TTO staff, UCD faculty and pharmaceutical and biotechnology industry leaders to commercialize new biomedical products and technologies. He negotiated and reviewed UCD licensing and collaboration agreements and other intellectual property (IP)-related contracting activities and led several UCD business development initiatives and programs at the UCD Anschutz Medical Campus, including startup company formation, development, financing and strategy. He was on the board of directors for the Colorado Institute for Drug, Device, and Diagnostic Development; the Colorado BioScience Association; and also was interim director of the Fitzsimons BioBusiness Partners Incubator in Aurora, Colo. (2007-2008), an advisory group serving the Colorado bioscience community.

Dr. Silva’s areas of business/commercialization interest include preclinical drug development; inflammation and immunity; vaccine development; oncology; biomarkers and pharmacodiagnostics; translational medicine; seed financing and venture capital; and business development.

Dr. Silva received his doctorate in physiology, with an emphasis in molecular endocrinology and molecular biology, from Colorado State University in 2000. He also holds a Masters of Business Administration in entrepreneurship and finance from the University of Colorado Boulder and a Bachelor of Science in agriculture with a minor in chemistry from New Mexico State University.